Evidence map›Paper›PMID 31340906›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2019

[Matrine inhibits proliferation and promotes autophagy and apoptosis in non-small cell lung cancer cells by deactivating PI3K/AKT/mTOR pathway].

Yanmei Hao, Hongmei Yin, Chaomang Zhu, Feng Li, Yingjie Zhang, Yuyun Li, Xiaojing Wang, Duojie Li

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. [Aumolertinib inhibits growth of human choroidal melanoma MUM-2B cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  4. Article
  5. Review
  6. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  7. Article
  8. Article
  9. Research Advances on Matrine.Frontiers in chemistry · 2022
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yanmei HaoDepartment of Clinical Laboratory, Bengbu Medical College, Bengbu 233030, China.
Hongmei YinDepartment of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
Chaomang ZhuDepartment of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
Feng LiDepartment of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
Yingjie ZhangDepartment of Clinical Laboratory, Bengbu Medical College, Bengbu 233030, China.
Yuyun LiDepartment of Clinical Laboratory, Bengbu Medical College, Bengbu 233030, China.
Xiaojing WangAnhui Clinical and Preclinical Key laboratory of Respiratory Disease, Bengbu Medical College, Bengbu 233030, China.
Duojie LiDepartment of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
First Affiliated Hospital of Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the inhibitory effect of matrine on the proliferation of human non-small cell lung cancer (NSCLC) and explore the possible molecular mechanism.

methodsCultured human NSCLC A549 cells were treated with 0.4, 0.8, 1.2, 1.6, and 2.0 g/L matrine for 24, 48 or 72 h. CCK-8 assay was used for measuring the changes in A549 cell viability. The morphological changes of the cells were observed under a fluorescence microscope, and flow cytometry was employed for analyzing the cell apoptosis. The effects of matrine and the PI3K specific inhibitor LY294002 (10 nmol/L) on AKT pathway and autophagy-related proteins in A549 cells were investigated using Western blotting.

resultsMatrine significantly inhibited the proliferation of A549 cells in a time- and dose-dependent manner (

conclusionsWe demonstrate that matrine inhibits the proliferation and induces autophagy and apoptosis of A549 cells by deactivating AKT pathway, suggesting the potential of matrine as an anti-cancer agent for lung cancer.

Indexed as

AutophagyCarcinoma, Non-Small-Cell LungLung NeoplasmsAlkaloidsApoptosisCell ProliferationHumansMatrinesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktQuinolizinesSignal TransductionTOR Serine-Threonine KinasesAlkaloidsMatrinesMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktQuinolizinesTOR Serine-Threonine KinasesAKT pathwayapoptosisautophagymatrinenon-small cell lung cancer

Identifiers

PMID31340906
PMCPMC6765564
OpenAlexW2967752496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.